These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 37530724)
1. Next-Generation Bone Stimulation: Doubling Down on Bone Anabolics: Commentary on an article by Monica Florio, PhD, et al.: "Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone. An Experimental Study in Nonhuman Primates". van Wijnen AJ; Dashti P J Bone Joint Surg Am; 2023 Aug; 105(15):e38. PubMed ID: 37530724 [No Abstract] [Full Text] [Related]
2. Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone: An Experimental Study in Nonhuman Primates. Florio M; Kostenuik PJ; Stolina M; Asuncion FJ; Grisanti M; Ke HZ; Ominsky MS J Bone Joint Surg Am; 2023 Aug; 105(15):1145-1155. PubMed ID: 37159527 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones. Ominsky MS; Li C; Li X; Tan HL; Lee E; Barrero M; Asuncion FJ; Dwyer D; Han CY; Vlasseros F; Samadfam R; Jolette J; Smith SY; Stolina M; Lacey DL; Simonet WS; Paszty C; Li G; Ke HZ J Bone Miner Res; 2011 May; 26(5):1012-21. PubMed ID: 21542004 [TBL] [Abstract][Full Text] [Related]
4. Sclerostin monoclonal antibodies on bone metabolism and fracture healing. Gamie Z; Korres N; Leonidou A; Gray AC; Tsiridis E Expert Opin Investig Drugs; 2012 Oct; 21(10):1523-34. PubMed ID: 22849579 [TBL] [Abstract][Full Text] [Related]
5. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386 [TBL] [Abstract][Full Text] [Related]
6. Dkk1 KO Mice Treated with Sclerostin Antibody Have Additional Increases in Bone Volume. Morse A; Cheng TL; Schindeler A; McDonald MM; Mohanty ST; Kneissel M; Kramer I; Little DG Calcif Tissue Int; 2018 Sep; 103(3):298-310. PubMed ID: 29845410 [TBL] [Abstract][Full Text] [Related]
7. Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength. Ominsky MS; Vlasseros F; Jolette J; Smith SY; Stouch B; Doellgast G; Gong J; Gao Y; Cao J; Graham K; Tipton B; Cai J; Deshpande R; Zhou L; Hale MD; Lightwood DJ; Henry AJ; Popplewell AG; Moore AR; Robinson MK; Lacey DL; Simonet WS; Paszty C J Bone Miner Res; 2010 May; 25(5):948-59. PubMed ID: 20200929 [TBL] [Abstract][Full Text] [Related]
8. Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene. Li C; Ominsky MS; Tan HL; Barrero M; Niu QT; Asuncion FJ; Lee E; Liu M; Simonet WS; Paszty C; Ke HZ Bone; 2011 Dec; 49(6):1178-85. PubMed ID: 21890008 [TBL] [Abstract][Full Text] [Related]
9. Hyperthyroidism and Hypothyroidism in Male Mice and Their Effects on Bone Mass, Bone Turnover, and the Wnt Inhibitors Sclerostin and Dickkopf-1. Tsourdi E; Rijntjes E; Köhrle J; Hofbauer LC; Rauner M Endocrinology; 2015 Oct; 156(10):3517-27. PubMed ID: 26218891 [TBL] [Abstract][Full Text] [Related]
10. Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Ke HZ; Richards WG; Li X; Ominsky MS Endocr Rev; 2012 Oct; 33(5):747-83. PubMed ID: 22723594 [TBL] [Abstract][Full Text] [Related]
11. Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling. Jin H; Wang B; Li J; Xie W; Mao Q; Li S; Dong F; Sun Y; Ke HZ; Babij P; Tong P; Chen D Bone; 2015 Feb; 71():63-75. PubMed ID: 25263522 [TBL] [Abstract][Full Text] [Related]
12. Dkk1 haploinsufficiency requires expression of Bmp2 for bone anabolic activity. Intini G; Nyman JS Bone; 2015 Jun; 75():151-60. PubMed ID: 25603465 [TBL] [Abstract][Full Text] [Related]
13. Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition. Witcher PC; Miner SE; Horan DJ; Bullock WA; Lim KE; Kang KS; Adaniya AL; Ross RD; Loots GG; Robling AG JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875318 [TBL] [Abstract][Full Text] [Related]
14. Mechanically Driven Counter-Regulation of Cortical Bone Formation in Response to Sclerostin-Neutralizing Antibodies. Gerbaix M; Ammann P; Ferrari S J Bone Miner Res; 2021 Feb; 36(2):385-399. PubMed ID: 33049076 [TBL] [Abstract][Full Text] [Related]
15. Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury. Li X; Grisanti M; Fan W; Asuncion FJ; Tan HL; Dwyer D; Han CY; Yu L; Lee J; Lee E; Barrero M; Kurimoto P; Niu QT; Geng Z; Winters A; Horan T; Steavenson S; Jacobsen F; Chen Q; Haldankar R; Lavallee J; Tipton B; Daris M; Sheng J; Lu HS; Daris K; Deshpande R; Valente EG; Salimi-Moosavi H; Kostenuik PJ; Li J; Liu M; Li C; Lacey DL; Simonet WS; Ke HZ; Babij P; Stolina M; Ominsky MS; Richards WG J Bone Miner Res; 2011 Nov; 26(11):2610-21. PubMed ID: 21773994 [TBL] [Abstract][Full Text] [Related]
16. Anti-sclerostin - is there an indication? Larsson S Injury; 2016 Jan; 47 Suppl 1():S31-5. PubMed ID: 26768288 [TBL] [Abstract][Full Text] [Related]
17. Wnt Inhibitors and Bone Mineral Density in Patients with Graves' Disease Treated with Antithyroid Drugs: A Preliminary Prospective Study. Mudri D; Kizivat T; Mihaljević I; Bilić Ćurčić I Metabolites; 2022 Jul; 12(8):. PubMed ID: 36005583 [TBL] [Abstract][Full Text] [Related]
18. Impaired Bone Microarchitecture in Premenopausal Women With Acromegaly: The Possible Role of Wnt Signaling. Silva PPB; Pereira RMR; Takayama L; Borba CG; Duarte FH; Trarbach EB; Martin RM; Bronstein MD; Tritos NA; Jallad RS J Clin Endocrinol Metab; 2021 Aug; 106(9):2690-2706. PubMed ID: 33871626 [TBL] [Abstract][Full Text] [Related]
19. Fracture repair: general aspects and influence of osteoporosis and anti-osteoporosis treatment. Féron JM; Mauprivez R Injury; 2016 Jan; 47 Suppl 1():S10-4. PubMed ID: 26768282 [TBL] [Abstract][Full Text] [Related]
20. A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair. Florio M; Gunasekaran K; Stolina M; Li X; Liu L; Tipton B; Salimi-Moosavi H; Asuncion FJ; Li C; Sun B; Tan HL; Zhang L; Han CY; Case R; Duguay AN; Grisanti M; Stevens J; Pretorius JK; Pacheco E; Jones H; Chen Q; Soriano BD; Wen J; Heron B; Jacobsen FW; Brisan E; Richards WG; Ke HZ; Ominsky MS Nat Commun; 2016 May; 7():11505. PubMed ID: 27230681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]